MLE and Bayesian Inference of Age‐Dependent Sensitivity and Transition Probability in Periodic Screening

This article extends previous probability models for periodic breast cancer screening examinations. The specific aim is to provide statistical inference for age dependence of sensitivity and the transition probability from the disease free to the preclinical state. The setting is a periodic screening program in which a cohort of initially asymptomatic women undergo a sequence of breast cancer screening exams. We use age as a covariate in the estimation of screening sensitivity and the transition probability simultaneously, both from a frequentist point of view and within a Bayesian framework. We apply our method to the Health Insurance Plan of Greater New York study of female breast cancer and give age-dependent sensitivity and transition probability density estimates. The inferential methodology we develop is also applicable when analyzing studies of modalities for early detection of other types of progressive chronic diseases.

[1]  L. Tierney Markov Chains for Exploring Posterior Distributions , 1994 .

[2]  K. Kerlikowske,et al.  Effect of age, breast density, and family history on the sensitivity of first screening mammography. , 1996, JAMA.

[3]  Benefits of screening for breast cancer: application of a probabilistic model to a breast cancer detection project. , 1979, Journal of chronic diseases.

[4]  L. Tabár,et al.  Estimation of Sojourn Time in Chronic Disease Screening Without Data on Interval Cases , 2000, Biometrics.

[5]  M. Zelen,et al.  Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding , 1999 .

[6]  H Straatman,et al.  Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group. , 1997, Biometrics.

[7]  P. Prorok,et al.  Bmc Medical Research Methodology Open Access Using Observational Data to Estimate an Upper Bound on the Reduction in Cancer Mortality Due to Periodic Screening , 2022 .

[8]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  S. Baker Evaluating the age to begin periodic breast cancer screening using data from a few regularly scheduled screenings. , 1998, Biometrics.

[10]  S D Walter,et al.  Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.

[11]  N. Day,et al.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. , 1984, Biometrics.

[12]  R. Greenberg,et al.  Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening. , 1986, Cancer research.

[13]  Marvin Zelen,et al.  Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer , 1998 .

[14]  Marvin Zelen,et al.  Optimal scheduling of examinations for the early detection of disease , 1993 .

[15]  M Zelen,et al.  Testing the Independence of Two Diagnostic Tests , 2001, Biometrics.

[16]  A. Miller,et al.  Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .